Your browser doesn't support javascript.
loading
Induction of adaptive immune responses against antigens incorporated within the capsid of simian virus 40.
Saika, Kikue; Kato, Masahiko; Sanada, Hideaki; Matsushita, Sho; Matsui, Masanori; Handa, Hiroshi; Kawano, Masaaki.
Afiliación
  • Saika K; Department of Allergy and Immunology, Faculty of Medicine, Saitama Medical University, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.
  • Kato M; R&I Business Development, Business Strategy Development, Sysmex Corporation, 1-1-2 Murotani, Nishi-ku, Kobe 651-2241, Japan.
  • Sanada H; R&I Business Development, Business Strategy Development, Sysmex Corporation, 1-1-2 Murotani, Nishi-ku, Kobe 651-2241, Japan.
  • Matsushita S; Allergy Center, Saitama Medical University, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.
  • Matsui M; Department of Allergy and Immunology, Faculty of Medicine, Saitama Medical University, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.
  • Handa H; Department of Microbiology, Faculty of Medicine, Saitama Medical University, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan.
  • Kawano M; Department of Chemical Biology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
J Gen Virol ; 101(8): 853-862, 2020 08.
Article en En | MEDLINE | ID: mdl-32501197
ABSTRACT
Simian virus 40 (SV40) is a monkey polyomavirus. The capsid structure is icosahedral and comprises VP1 units that measure 45 nm in diameter. Five SV40 VP1 molecules form one pentamer subunit, and a single icosahedral subunit comprises 72 pentamers; a single SV40 VP1 capsid comprises 360 SV40 VP1 molecules. In a previous study, we showed that an influenza A virus matrix protein 1 (M1) CTL epitope inserted within SV40 virus-like particles (VLPs) induced cytotoxic T lymphocytes (CTLs) without the need for an adjuvant. Here, to address whether SV40 VLPs induce adaptive immune responses against VLP-incorporated antigens, we prepared SV40 VLPs containing M1 or chicken ovalbumin (OVA). This was done by fusing M1 or OVA with the carboxyl terminus of SV40 VP2 and co-expressing them with SV40 VP1 in insect cells using a baculovirus vector. Intraperitoneal (i.p.) or intranasal administration of SV40 VLPs incorporating M1 induced the production of CTLs specific for the M1 epitope without the requirement for adjuvant. The production of antibodies against SV40 VLPs was also induced by i.p. administration of SV40 VLPs in the absence of adjuvant. Finally, the administration of SV40 VLPs incorporating OVA induced anti-OVA antibodies in the absence of adjuvant; in addition, the level of antibody production was comparable with that after i.p. administration of OVA plus alum adjuvant. These results suggest that the SV40 capsid incorporating foreign antigens can be used as a vaccine platform to induce adaptive immune responses without the need for adjuvant.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cápside / Virus 40 de los Simios / Proteínas de la Cápside / Inmunidad Adaptativa / Antígenos Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cápside / Virus 40 de los Simios / Proteínas de la Cápside / Inmunidad Adaptativa / Antígenos Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article